Key Insights

Highlights

Treatment Research

2 treatments under study, led by Cerclage

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

100.0%

1 terminated out of 1 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Terminated1

Clinical Trials (1)

Research Network

Common Treatments

  • Cerclage1
  • Expectant Management1

Active Sponsors

  • St. Louis University1

Top Investigators

Activity Timeline